Lluís Force

Substitution of Nevirapine, Efavirenz, or Abacavir for Protease Inhibitors in Patients with Human Immunodeficiency Virus Infection

Estebán Martínez, Juan A. Arnaiz, Daniel Podzamczer et al. · New England Journal of Medicine · 2003 · 293 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Oropharyngeal Dysphagia is a Risk Factor for Readmission for Pneumonia in the Very Elderly Persons: Observational Prospective Study

Mateu Serra‐Prat, Lluís Force, Jordi Almirall et al. · The Journals of Gerontology Series A · 2013 · 205 citations

Medicine, Geriatric Medicine, Dysphagia +16

Long-term Mortality in HIV-Positive Individuals Virally Suppressed for >3 Years With Incomplete CD4 Recovery

Frederik Neess Engsig, Robert Zangerle, François Dabis et al. · Clinical Infectious Diseases · 2014 · 172 citations · Full text

Public Health, Biostatistics, Infectious Diseases +14

A Randomized Clinical Trial Comparing Nelfinavir Or Nevirapine Associated to Zidovudine/Lamivudine in HIV-Infected Naive Patients (The Combine Study)

Daniel Podzamczer, Elena Ferrer, Ezequiel Consiglio et al. · Antiviral Therapy · 2002 · 137 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study

Daniel K. Nomah, Juliana Reyes‐Urueña, Yesika Díaz et al. · The Lancet HIV · 2021 · 110 citations · Full text

Public Health, Health Sciences, Infectious Diseases +17